Simon Miles Ball
Direttore/Membro del Consiglio presso Exelead, Inc.
Profilo
Simon Miles Ball is currently a Director at Exelead, Inc., a Director at Leadiant Biosciences Ltd., the Global Head-Business Development at Leadiant Biosciences, Inc., and the Country General Manager at Leadiant Biosciences SpA.
He previously worked as a Non-Executive Director at Lee's Pharmaceutical Holdings Ltd.
from 2017 to 2021.
Mr. Ball received an undergraduate degree from the University of Leeds.
Posizioni attive di Simon Miles Ball
| Società | Posizione | Inizio |
|---|---|---|
Exelead, Inc.
 Exelead, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Exelead, Inc. is a biopharmaceutical contract development and manufacturing company. The company is based in Indianapolis, IN. John Rigg has been the CEO of the company since 2014. Exelead was acquired by Merck KGaA from Leadiant Biosciences SA on February 23, 2022 for $780 million. | Direttore/Membro del Consiglio | - |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Corporate Officer/Principal | - |
Leadiant Biosciences Ltd.
 Leadiant Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences Ltd. researches, manufactures, and markets therapies for patients. The private company is based in London, UK, and has subsidiaries in Germany. The British company was founded in 1957. Antonio Gama da Silva has been the CEO of the company since 2016. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Simon Miles Ball
| Società | Posizione | Fine |
|---|---|---|
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Direttore/Membro del Consiglio | 30/06/2021 |
Formazione di Simon Miles Ball
| University of Leeds | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
Exelead, Inc.
Exelead, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Exelead, Inc. is a biopharmaceutical contract development and manufacturing company. The company is based in Indianapolis, IN. John Rigg has been the CEO of the company since 2014. Exelead was acquired by Merck KGaA from Leadiant Biosciences SA on February 23, 2022 for $780 million. | Health Technology |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Health Technology |
Leadiant Biosciences Ltd.
Leadiant Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences Ltd. researches, manufactures, and markets therapies for patients. The private company is based in London, UK, and has subsidiaries in Germany. The British company was founded in 1957. Antonio Gama da Silva has been the CEO of the company since 2016. | Health Technology |
- Borsa valori
- Insiders
- Simon Miles Ball
